These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15017068)

  • 1. RNase P-mediated inhibition of viral growth by exogenous administration of short oligonucleotide external guide sequence.
    Dunn W; Liu F
    Methods Mol Biol; 2004; 252():425-36. PubMed ID: 15017068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective inhibition of Rta expression and lytic replication of Kaposi's sarcoma-associated herpesvirus by human RNase P.
    Zhu J; Trang P; Kim K; Zhou T; Deng H; Liu F
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9073-8. PubMed ID: 15184661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro selection of external guide sequences for directing human RNase P to cleave a target mRNA.
    Raj S; Liu F
    Methods Mol Biol; 2004; 252():413-24. PubMed ID: 15017067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the expression of the human RNase P protein subunits Rpp21, Rpp25, Rpp29 by external guide sequences (EGSs) and siRNA.
    Zhang H; Altman S
    J Mol Biol; 2004 Sep; 342(4):1077-83. PubMed ID: 15351636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNase P-mediated inhibition of cytomegalovirus protease expression and viral DNA encapsidation by oligonucleotide external guide sequences.
    Dunn W; Trang P; Khan U; Zhu J; Liu F
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14831-6. PubMed ID: 11742095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNase P ribozyme as an antiviral agent against human cytomegalovirus.
    Trang P; Liu F
    Methods Mol Biol; 2004; 252():437-50. PubMed ID: 15017069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human cytomegalovirus major capsid protein expression and replication by ribonuclease P-associated external guide sequences.
    Deng Q; Liu Y; Li X; Yan B; Sun X; Tang W; Trang P; Yang Z; Gong H; Wang Y; Lu J; Chen J; Xia C; Xing X; Lu S; Liu F
    RNA; 2019 May; 25(5):645-655. PubMed ID: 30803999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins.
    Kim K; Trang P; Umamoto S; Hai R; Liu F
    Nucleic Acids Res; 2004; 32(11):3427-34. PubMed ID: 15220469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic M1GS RNA as an antiviral agent in animals.
    Bai Y; Rider PJ; Liu F
    Methods Mol Biol; 2010; 629():339-53. PubMed ID: 20387160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of gene expression by RNase P.
    Lundblad EW; Altman S
    N Biotechnol; 2010 Jul; 27(3):212-21. PubMed ID: 20211282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An RNA external guide sequence ribozyme targeting human interleukin-4 receptor alpha mRNA.
    Dreyfus DH; Matczuk A; Fuleihan R
    Int Immunopharmacol; 2004 Aug; 4(8):1015-27. PubMed ID: 15222976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directing RNase P-mediated cleavage of target mRNAs by engineered external guide sequences in cultured cells.
    Jiang X; Sunkara N; Lu S; Liu F
    Methods Mol Biol; 2014; 1103():45-56. PubMed ID: 24318885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting mRNAs by engineered sequence-specific RNase P ribozymes.
    Bai Y; Sunkara N; Liu F
    Methods Mol Biol; 2012; 848():357-68. PubMed ID: 22315080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General design and construction of RNase P ribozymes for gene-targeting applications.
    Zou H; Chan K; Trang P; Liu F
    Methods Mol Biol; 2004; 252():385-98. PubMed ID: 15017065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro selection of RNase P ribozymes that efficiently cleave a target mRNA.
    Kim K; Liu F
    Methods Mol Biol; 2004; 252():399-412. PubMed ID: 15017066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DNA-EGS1386 in cells induced RNase P inhibits the expression of human cytomegalovirus UL49 gene].
    Cui Y; Zeng Z; Li H; Li Y; Zhou Q; Yang D; Zou Y; Yang G; Zhou T
    Sheng Wu Gong Cheng Xue Bao; 2009 Nov; 25(11):1690-6. PubMed ID: 20222469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonuclease P-mediated inhibition of human cytomegalovirus gene expression and replication induced by engineered external guide sequences.
    Jiang X; Chen YC; Gong H; Trang P; Lu S; Liu F
    RNA Biol; 2012 Sep; 9(9):1186-95. PubMed ID: 23018778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered external guide sequences effectively block viral gene expression and replication in cultured cells.
    Jiang X; Bai Y; Rider P; Kim K; Zhang CY; Lu S; Liu F
    J Biol Chem; 2011 Jan; 286(1):322-30. PubMed ID: 20980254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study on phenotypic conversion of clinical chloromycetin-resistant strains of E. coli to drug-sensitive strains by using EGS technique in vitro].
    Gao MY; Chen R; Liu SG; Feng JN
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1294-8. PubMed ID: 15387969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing RNase P ribozymes for gene-targeting and antiviral therapy.
    Trang P; Kim K; Liu F
    Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.